BioCentury | Jun 7, 2010
Financial News

Cynapsus amends private placement of units

...Type: Private placement of units To be raised: Up to C$2.5 million (US$2.4 million) Underwriter: Wellington West...
BioCentury | May 25, 2005
Financial News

Liponex files for IPO

...on a best efforts basis through Jennings Capital; Canaccord Capital; Haywood Securities; Dundee Securities; and Wellington West...
BioCentury | Jan 3, 2005
Finance

Ebb & Flow

...cell lung cancer (NSCLC). The deal was underwritten by Canaccord; Jennings Capital; McFarlane Gordon; and Wellington West...
BioCentury | Dec 30, 2004
Financial News

Chemokine prices IPO

...post-money valuation of C$29.3 million ($23.8 million). Underwriters were Canaccord; Jennings Capital; McFarlane Gordon; and Wellington West...
BioCentury | Dec 1, 2000
Financial News

Medicure to raise up to C$20 million

...to C$20 million (US$13 million) in a unit offering in Canada through Groome Capital.com and Wellington West...
Items per page:
1 - 5 of 5
BioCentury | Jun 7, 2010
Financial News

Cynapsus amends private placement of units

...Type: Private placement of units To be raised: Up to C$2.5 million (US$2.4 million) Underwriter: Wellington West...
BioCentury | May 25, 2005
Financial News

Liponex files for IPO

...on a best efforts basis through Jennings Capital; Canaccord Capital; Haywood Securities; Dundee Securities; and Wellington West...
BioCentury | Jan 3, 2005
Finance

Ebb & Flow

...cell lung cancer (NSCLC). The deal was underwritten by Canaccord; Jennings Capital; McFarlane Gordon; and Wellington West...
BioCentury | Dec 30, 2004
Financial News

Chemokine prices IPO

...post-money valuation of C$29.3 million ($23.8 million). Underwriters were Canaccord; Jennings Capital; McFarlane Gordon; and Wellington West...
BioCentury | Dec 1, 2000
Financial News

Medicure to raise up to C$20 million

...to C$20 million (US$13 million) in a unit offering in Canada through Groome Capital.com and Wellington West...
Items per page:
1 - 5 of 5